Answers are grounded in this paper and cite their sources.
This study examined NEDD4 expression in tracheobronchial tuberculosis (TBTB) lesions and investigated its function in macrophage polarization in H37Rv whole-cell lysate (WCL)-stimulated mouse bone marrow-derived macrophages (BMDMs). In clinical samples, NEDD4 was downregulated in TBTB lesions and colocalized with the macrophage marker CD68, accompanied by mucosal disruption and inflammatory infiltration. In H37Rv WCL-stimulated BMDMs, NEDD4 overexpression suppressed M1 markers and pro-inflammatory cytokines (IL-6, TNF-α, IL-1β, IL-12), while promoting M2 markers and anti-inflammatory cytokines (IL-10, TGF-β). NEDD4-overexpressing macrophages also attenuated bronchial epithelial cell damage in a co-culture system. Conversely, NEDD4 knockdown exerted opposite effects. Mechanistically, NEDD4 enhanced autophagic flux via upregulation of Beclin1 and augmented mitochondrial oxidative phosphorylation (OXPHOS). Pharmacological inhibition of autophagy with 3-MA or OXPHOS with oligomycin attenuated the NEDD4-induced M2 polarization. NEDD4 interacted with TLR4 and promoted its ubiquitination and degradation, inhibiting the TRAF6/NF-κB pathway and upregulating PGC-1β. TLR4 overexpression abolished NEDD4-mediated OXPHOS enhancement, which was restored by co-overexpression of PGC-1β. Collectively, these findings suggest that in experimental models, NEDD4 promotes M2 polarization through Beclin1-dependent autophagy and TLR4/TRAF6/NF-κB/PGC-1β-mediated OXPHOS reprogramming, thereby attenuating bronchial epithelial damage. These results identify NEDD4 as a potential candidate for further investigation in TBTB.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: